Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Liver Cirrhosis

Free Subscription 16.03.2026 1 BMC Gastroenterol 1 Clin Res Hepatol Gastroenterol 2 Dig Dis Sci 1 Gastroenterology 4 J Gastroenterol Hepatol 3 PLoS One 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. COURET A, Rannou F, Pereira B, Duclos M, et al
   Systematic review of prognostic value of cardiorespiratory fitness in patients with cirrhosis.
   BMC Gastroenterol. 2026 Mar 11. doi: 10.1186/s12876-026-04715.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

2. MOKKAPATI A, Thakkar R, Rani A, Puri D, et al
   Comment on "Sequential Anticoagulation with LMWH and DOACs in Cirrhotic Portal Vein Thrombosis".
   Clin Res Hepatol Gastroenterol. 2026 Mar 10:102806.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

3. SPANN A, Louissaint J
   Advancing Advance Directive Completion Rates in Patients with Decompensated Cirrhosis.
   Dig Dis Sci. 2026 Mar 11. doi: 10.1007/s10620-026-09815.
   PubMed        
   
   
4. WU YT, Li QZ, Zhao XK, Mu M, et al
   Anlotinib Attenuates Liver Fibrosis by Regulating the Transforming Growth Factor beta1/Smad3 Signaling Pathway.
   Dig Dis Sci. 2023;68:4186-4195.
   PubMed         Abstract available
   
   

   
   Gastroenterology

5. SARIN SK, Tripathti DM, Lohse AW
   Non-cirrhotic Portal Fibrosis, Idiopathic Portal Hypertension and Porto-sinusoidal Vascular Diseases: From Debates to Future Directions.
   Gastroenterology. 2026 Mar 10:S0016-5085(26)00199.
   PubMed        
   
   

   
   J Gastroenterol Hepatol

6. MUJAHID MUF, Haider E
   A Critical Assessment of "Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV-Related Cirrhosis: A Landmark Analysis".
   J Gastroenterol Hepatol. 2026 Mar 7. doi: 10.1111/jgh.70328.
   PubMed        
   
   
7. O'HARA SP, Bogert PT, Dickinson S, Chen X, et al
   Plasma Biomarkers of Senescence in Cholestatic Liver Disease: A Signature of Risk Stratification and Progression.
   J Gastroenterol Hepatol. 2026 Feb 13. doi: 10.1111/jgh.70279.
   PubMed         Abstract available
   
   
8. HSIEH ML, Su TH, Lin YC, Chen YY, et al
   Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease.
   J Gastroenterol Hepatol. 2026;41:1041-1051.
   PubMed         Abstract available
   
   
9. LI Y, Li J, Dullaart RPF, Moshage H, et al
   Bacterial Extracellular Vesicles in the Pathogenesis and Treatment of Liver Diseases.
   J Gastroenterol Hepatol. 2026;41:880-894.
   PubMed         Abstract available
   
   

   
   PLoS One

10. IBI Y, Omori T
    Cure rate estimation with insufficient follow-up: A median-based bootstrap correction approach.
    PLoS One. 2026;21:e0344669.
    PubMed         Abstract available
    
    
11. DESALEGN MM, Fisseha H, Altaye MG, Berhane KA, et al
    Prevalence and associated factors of non-variceal upper gastrointestinal bleeding among cirrhotic patients with upper gastrointestinal bleeding on follow-up at a Tertiary Hospital in Ethiopia.
    PLoS One. 2026;21:e0343977.
    PubMed         Abstract available
    
    
12. LEI Y, Ma X, Jin X, He Y, et al
    Huanggan decoction ameliorates cholestatic hepatic fibrosis in rats via TGF-beta1/Smad3 signaling pathway.
    PLoS One. 2026;21:e0344168.
    PubMed         Abstract available
    
    

    
    Transplant Proc

13. TOSHIDA K, Toshima T, Itoh S, Yoshiya S, et al
    Caution to Poor Adherence With Immunosuppressant Medication That Causes Coma-Onset Autoimmune Encephalitis: A Case Report and Literature Review.
    Transplant Proc. 2023;55:1968-1971.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum